2026, patient information sheet, attached document.[3] Therapeutic Goods Administration (TGA) 2025, ACM meeting statement, Meeting 53, 3 October 2025, TGA.[1] Diabetes Australia 2024, Wegovy to be available in Australia, Diabetes Australia.[4] Hormones Australia 2023, New diabetes drug Mounjaro approved by the TGA, Hormones Australia.[5] Pharmacy Daily 2022, Wegovy gets green light from TGA, Pharmacy Daily.[6] RACGP 2025, Wegovy approved for cutting cardiovascular disease risk, RACGP.[7] Semaglutide-use-and-NAION-risks-with-references.docx
Chahrour and Zoghbi, 2007
This means the medication was never intended to work in a vacuum
aureus are classified as of high importance 1
Then we talk about injections, go over probable side effects, answer any questions you have, and make a clear plan if GLP-1 is right for you
Still, its safety also hinges on several factors, including supervision and product quality